Effectiveness of Orthokeratology in Myopia Control
Myopia
About this trial
This is an interventional prevention trial for Myopia
Eligibility Criteria
Inclusion Criteria:
- myopia progression more than -1.00D in one year
- myopic prescription between -1.00D and -6.00D in at least one eye with refractive astigmatism <1.50D
- Best corrected VA 20/25 or better
- subjects willing to present to clinic for all necessary follow up care
- willing to be randomized to either group
Exclusion Criteria:
- non-compliance with treatment protocol
- contraindications for orthok as per company guidelines
- history of refractive surgery
- current gas permeable contact lens wearers
Sites / Locations
- Illinois Eye Institute
Arms of the Study
Arm 1
Arm 2
Experimental
No Intervention
Experimental-OrthoK
Control
The study will be a randomized control study using a single-masked design to investigate axial elongation and myopic progression in children wearing ortho-k lenses (study group) versus single-vision spectacles or soft contact lenses (control group) for a period of 24 months. A minimum of 40 and a maximum of 60 subjects will be recruited from patients at Illinois Eye Institute. Once eligibility has been determined by an unmasked observer, patients will be randomly assigned to either the orthokeratology group or the single-vision contact lens /spectacle group
The study will be a randomized control study using a single-masked design to investigate axial elongation and myopic progression in children wearing ortho-k lenses (study group) versus single-vision spectacles (control group) for a period of 24 months. A minimum of 40 and a maximum of 60 subjects will be recruited from patients at Illinois Eye Institute. Once eligibility has been determined by an unmasked observer, patients will be randomly assigned to either the orthokeratology group or the single-vision contact lens /spectacle group